Sensex Slumps After Reports Experimental Covid-19 Drug Fails First Trial

Benchmark indices in India followed global markets, which were sharply lower after reports that Gilead Sciences Inc's experimental coronavirus drug failed its first randomised clinical trial, citing draft documents published accidentally by the World Health Organization. Sentiments were also adversely impacted

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/356Wr2e